Degrome Therapeutics, Inc.
Indianapolis, IN
- UEI
- PSPLN2KBM7C9
- CAGE
- Not on record
- Primary NAICS
- Not on record
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Physical address
- 1800 N Capitol Ave e530, Indianapolis, IN 46202, USA
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Development of small-molecule degraders of APP as the first-in-class drugs for alzheimer's therapy - project… | National Institute on Aging | $499,883 |
Quick answers
What is Degrome Therapeutics, Inc.'s UEI?
Degrome Therapeutics, Inc.'s Unique Entity ID (UEI) in SAM.gov is PSPLN2KBM7C9.
Where is Degrome Therapeutics, Inc. located?
Degrome Therapeutics, Inc.'s physical address in SAM.gov is 1800 N Capitol Ave e530, Indianapolis, IN 46202, USA.
Is Degrome Therapeutics, Inc. registered in SAM.gov?
Yes. Degrome Therapeutics, Inc.'s SAM.gov registration is active through September 9, 2027.
What is Degrome Therapeutics, Inc.'s most recent federal award?
Degrome Therapeutics, Inc.'s most recent federal grant award is Development of small-molecule degraders of APP as the first-in-class drugs for alzheimer's therapy - project… (R41AG090241), from National Institute on Aging, on September 1, 2024.
On GovTribe
See Degrome Therapeutics, Inc.'s full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors